Thrombolytic Therapy for Stroke:
Tissue plasminogen activator (t-PA) is the only treatment currently proven to benefit stroke victims, but no physician guide to its safe and proper use exists. In Thrombolytic Therapy for Stroke, the world's leading experts detail the basic rationale, scientific evidence, and treatment protocol...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Totowa, NJ
Humana Press
2001
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | Tissue plasminogen activator (t-PA) is the only treatment currently proven to benefit stroke victims, but no physician guide to its safe and proper use exists. In Thrombolytic Therapy for Stroke, the world's leading experts detail the basic rationale, scientific evidence, and treatment protocol for thrombolytic therapy in acute stroke patients. These experienced clinicians show how promptly delivered thrombolysis can restore cerebral blood flow in time to salvage brain and neurologic function, first by reviewing the preclinical development of thrombolytics, and then by presenting the pivotal clinical trials that proved their efficacy and safety. Their description of the treatment protocol discusses field triage and management, emergency department therapy, brain imaging, clinical decision making and patient selection, drug administration, post--thrombolysis management, and the treatment of complications. Real-life programmed case histories-complete with commentary and brain images-illustrate the use of the thrombolytic therapy protocol and illuminate its special indications and contraindications. Comprehensive and highly practical, Thrombolytic Therapy for Stroke offers the practicing physician everything necessary-background, protocols, and case studies-for the safe and effective treatment of the emergency stroke patient today |
| Beschreibung: | 1 Online-Ressource (XIV, 410 p. 73 illus., 2 illus. in color) |
| ISBN: | 9781592591312 |
| DOI: | 10.1007/978-1-59259-131-2 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046144046 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s2001 |||| o||u| ||||||eng d | ||
| 020 | |a 9781592591312 |9 978-1-59259-131-2 | ||
| 024 | 7 | |a 10.1007/978-1-59259-131-2 |2 doi | |
| 035 | |a (ZDB-2-SME)978-1-59259-131-2 | ||
| 035 | |a (OCoLC)1119018634 | ||
| 035 | |a (DE-599)BVBBV046144046 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.8 |2 23 | |
| 084 | |a YG 5115 |0 (DE-625)153503:12921 |2 rvk | ||
| 245 | 1 | 0 | |a Thrombolytic Therapy for Stroke |c edited by Patrick D. Lyden |
| 264 | 1 | |a Totowa, NJ |b Humana Press |c 2001 | |
| 300 | |a 1 Online-Ressource (XIV, 410 p. 73 illus., 2 illus. in color) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a Tissue plasminogen activator (t-PA) is the only treatment currently proven to benefit stroke victims, but no physician guide to its safe and proper use exists. In Thrombolytic Therapy for Stroke, the world's leading experts detail the basic rationale, scientific evidence, and treatment protocol for thrombolytic therapy in acute stroke patients. These experienced clinicians show how promptly delivered thrombolysis can restore cerebral blood flow in time to salvage brain and neurologic function, first by reviewing the preclinical development of thrombolytics, and then by presenting the pivotal clinical trials that proved their efficacy and safety. Their description of the treatment protocol discusses field triage and management, emergency department therapy, brain imaging, clinical decision making and patient selection, drug administration, post--thrombolysis management, and the treatment of complications. Real-life programmed case histories-complete with commentary and brain images-illustrate the use of the thrombolytic therapy protocol and illuminate its special indications and contraindications. Comprehensive and highly practical, Thrombolytic Therapy for Stroke offers the practicing physician everything necessary-background, protocols, and case studies-for the safe and effective treatment of the emergency stroke patient today | ||
| 650 | 4 | |a Neurology | |
| 650 | 4 | |a Neurology | |
| 650 | 0 | 7 | |a Fibrinolysetherapie |0 (DE-588)4212438-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Schlaganfall |0 (DE-588)4052588-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Schlaganfall |0 (DE-588)4052588-0 |D s |
| 689 | 0 | 1 | |a Fibrinolysetherapie |0 (DE-588)4212438-4 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Lyden, Patrick D. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781475768435 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781475768428 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780896037465 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-59259-131-2 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031524230 | ||
| 966 | e | |u https://doi.org/10.1007/978-1-59259-131-2 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180478917345280 |
|---|---|
| any_adam_object | |
| author2 | Lyden, Patrick D. |
| author2_role | edt |
| author2_variant | p d l pd pdl |
| author_facet | Lyden, Patrick D. |
| building | Verbundindex |
| bvnumber | BV046144046 |
| classification_rvk | YG 5115 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-1-59259-131-2 (OCoLC)1119018634 (DE-599)BVBBV046144046 |
| dewey-full | 616.8 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.8 |
| dewey-search | 616.8 |
| dewey-sort | 3616.8 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-1-59259-131-2 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03092nmm a2200481zc 4500</leader><controlfield tag="001">BV046144046</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s2001 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781592591312</subfield><subfield code="9">978-1-59259-131-2</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-59259-131-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-59259-131-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119018634</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046144046</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.8</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YG 5115</subfield><subfield code="0">(DE-625)153503:12921</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Thrombolytic Therapy for Stroke</subfield><subfield code="c">edited by Patrick D. Lyden</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, NJ</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2001</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIV, 410 p. 73 illus., 2 illus. in color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Tissue plasminogen activator (t-PA) is the only treatment currently proven to benefit stroke victims, but no physician guide to its safe and proper use exists. In Thrombolytic Therapy for Stroke, the world's leading experts detail the basic rationale, scientific evidence, and treatment protocol for thrombolytic therapy in acute stroke patients. These experienced clinicians show how promptly delivered thrombolysis can restore cerebral blood flow in time to salvage brain and neurologic function, first by reviewing the preclinical development of thrombolytics, and then by presenting the pivotal clinical trials that proved their efficacy and safety. Their description of the treatment protocol discusses field triage and management, emergency department therapy, brain imaging, clinical decision making and patient selection, drug administration, post--thrombolysis management, and the treatment of complications. Real-life programmed case histories-complete with commentary and brain images-illustrate the use of the thrombolytic therapy protocol and illuminate its special indications and contraindications. Comprehensive and highly practical, Thrombolytic Therapy for Stroke offers the practicing physician everything necessary-background, protocols, and case studies-for the safe and effective treatment of the emergency stroke patient today</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Fibrinolysetherapie</subfield><subfield code="0">(DE-588)4212438-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Schlaganfall</subfield><subfield code="0">(DE-588)4052588-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Schlaganfall</subfield><subfield code="0">(DE-588)4052588-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Fibrinolysetherapie</subfield><subfield code="0">(DE-588)4212438-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lyden, Patrick D.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781475768435</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781475768428</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780896037465</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-59259-131-2</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031524230</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-59259-131-2</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV046144046 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:24Z |
| institution | BVB |
| isbn | 9781592591312 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031524230 |
| oclc_num | 1119018634 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XIV, 410 p. 73 illus., 2 illus. in color) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 2001 |
| publishDateSearch | 2001 |
| publishDateSort | 2001 |
| publisher | Humana Press |
| record_format | marc |
| spelling | Thrombolytic Therapy for Stroke edited by Patrick D. Lyden Totowa, NJ Humana Press 2001 1 Online-Ressource (XIV, 410 p. 73 illus., 2 illus. in color) txt rdacontent c rdamedia cr rdacarrier Tissue plasminogen activator (t-PA) is the only treatment currently proven to benefit stroke victims, but no physician guide to its safe and proper use exists. In Thrombolytic Therapy for Stroke, the world's leading experts detail the basic rationale, scientific evidence, and treatment protocol for thrombolytic therapy in acute stroke patients. These experienced clinicians show how promptly delivered thrombolysis can restore cerebral blood flow in time to salvage brain and neurologic function, first by reviewing the preclinical development of thrombolytics, and then by presenting the pivotal clinical trials that proved their efficacy and safety. Their description of the treatment protocol discusses field triage and management, emergency department therapy, brain imaging, clinical decision making and patient selection, drug administration, post--thrombolysis management, and the treatment of complications. Real-life programmed case histories-complete with commentary and brain images-illustrate the use of the thrombolytic therapy protocol and illuminate its special indications and contraindications. Comprehensive and highly practical, Thrombolytic Therapy for Stroke offers the practicing physician everything necessary-background, protocols, and case studies-for the safe and effective treatment of the emergency stroke patient today Neurology Fibrinolysetherapie (DE-588)4212438-4 gnd rswk-swf Schlaganfall (DE-588)4052588-0 gnd rswk-swf Schlaganfall (DE-588)4052588-0 s Fibrinolysetherapie (DE-588)4212438-4 s DE-604 Lyden, Patrick D. edt Erscheint auch als Druck-Ausgabe 9781475768435 Erscheint auch als Druck-Ausgabe 9781475768428 Erscheint auch als Druck-Ausgabe 9780896037465 https://doi.org/10.1007/978-1-59259-131-2 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Thrombolytic Therapy for Stroke Neurology Fibrinolysetherapie (DE-588)4212438-4 gnd Schlaganfall (DE-588)4052588-0 gnd |
| subject_GND | (DE-588)4212438-4 (DE-588)4052588-0 |
| title | Thrombolytic Therapy for Stroke |
| title_auth | Thrombolytic Therapy for Stroke |
| title_exact_search | Thrombolytic Therapy for Stroke |
| title_full | Thrombolytic Therapy for Stroke edited by Patrick D. Lyden |
| title_fullStr | Thrombolytic Therapy for Stroke edited by Patrick D. Lyden |
| title_full_unstemmed | Thrombolytic Therapy for Stroke edited by Patrick D. Lyden |
| title_short | Thrombolytic Therapy for Stroke |
| title_sort | thrombolytic therapy for stroke |
| topic | Neurology Fibrinolysetherapie (DE-588)4212438-4 gnd Schlaganfall (DE-588)4052588-0 gnd |
| topic_facet | Neurology Fibrinolysetherapie Schlaganfall |
| url | https://doi.org/10.1007/978-1-59259-131-2 |
| work_keys_str_mv | AT lydenpatrickd thrombolytictherapyforstroke |